P018 Advancing Your Dermatologic Surgery Procedures and Practice
DESCRIPTION
From practical technologies that enhance surgical precision and efficiency, to emerging tools for predicting skin cancer outcomes, to techniques for preserving critical facial nerve anatomy and strategies for expanding access to care, our speakers will share innovations that directly impact patient outcomes. This session is designed so that every attendee, from the beginning surgeon to the most experienced dermatologic surgeon, will leave with some practical pearls they can immediately apply to improve patient care.
LEARNING OBJECTIVES
Implement practical technologies and workflow innovations to enhance diagnostic accuracy, surgical precision, and ergonomics,. Recognize and preserve critical facial nerve anatomy in high-risk surgical zones.
Apply contemporary risk stratification tools for cutaneous squamous cell carcinoma to improve prognostication, guide imaging decisions, and inform multidisciplinary treatment planning.
Develop strategies to improve access to skin cancer care through clinical innovation, advocacy, and systems-based approaches that address barriers faced by underserved populations.
SCHEDULE
8:45 AM
Discussion
8:45 AM
Discussion
DIRECTOR
Sumaira Zareen Aasi, MD, FAAD
SPEAKERS
Arif Aslam
Charlene Lam, MD, MPH, FAAD
Zakia Rahman, MD, FAAD
Stanford University School of Medicine
Taha Rasul, MD
Kathryn Shahwan, MD, FAAD
The Ohio State University
Zain U. Syed, MD, FAAD
Mohs and Skin Surgery Center, Skin Care Specialty Physicians
Junqian Zhang, MD, FAAD
Hospital of the University of Pennsylvania
DISCLOSURES
Sumaira Zareen Aasi, MD, FAAD
No financial relationships exist with ineligible companies.
Arif Aslam
No financial relationships exist with ineligible companies.
Charlene Lam, MD, MPH, FAAD
No financial relationships exist with ineligible companies.
Zakia Rahman, MD, FAAD
Allergan, Inc. – Advisory Board(Honoraria); Estee Lauder – Investigator(Grants/Research Funding);
Taha Rasul, MD
No financial relationships exist with ineligible companies.
Kathryn Shahwan, MD, FAAD
No financial relationships exist with ineligible companies.
Zain U. Syed, MD, FAAD
Castle Biosciences, Inc – Advisory Board(Honoraria), Speaker(Honoraria);
Junqian Zhang, MD, FAAD
No financial relationships exist with ineligible companies.